Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study
Titel:
Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study
Auteur:
Takashima, Atsuo García-Alfonso, Pilar Manneh, Raimundo Beşen, Ali Ayberk Hong, Yong Sang Cuyle, Pieter-Jan Yanez, Patricio Burge, Matthew Yoshino, Takayuki Kim, Tae Won Cui, Karen Li, Chenxiang Jain, Rishi Adelberg, David Taieb, Julien